ArticleMolecular biology reports2025
Biocontrol potential of Pseudomonas fluorescens: Phenazine mediated antifungal activity against phytopathogens.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The abilities of nitrogen-fixing bacteria to produce siderophores affect their promoting effects on cucumber growth and antiphytopathogenic fungus activities.Frontiers in microbiology · 2026Article
- Pseudomonas spp. and antimicrobial resistance: unlocking new horizons with 1-hydroxyphenazine.Folia microbiologica · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFungal phytopathogens pose significant threats to plant health and agricultural productivity. Biocontrol agents like Pseudomonas fluorescens offer eco-friendly alternatives to chemical fungicides. In this study, P. fluorescens was isolated from the rhizosphere of Vanda wightii and assessed for its potential as a biocontrol agent against key fungal pathogens.
methodsThe antagonistic activity of P. fluorescens was tested against Botrytis cinerea, Colletotrichum gloeosporioides, Fusarium oxysporum, and Rhizoctonia solani using dual plate and cross-streak assays. Siderophore and hydrogen cyanide production were evaluated as possible biocontrol mechanisms. Growth conditions were optimized by varying glycerol, tryptone, pH, and temperature. Phenazine, the main antifungal metabolite, was extracted and characterized using FTIR, HPLC, NMR, and mass spectrometry. Antifungal kinetics and membrane permeability assays were also conducted.
resultsP. fluorescens exhibited strong antagonism, forming clear inhibition zones against all tested pathogens. Optimal growth occurred with 2% glycerol, 2% tryptone, pH 7, and 35 °C. The purified phenazine showed significant antifungal activity, with inhibition zones of 18.29 ± 0.05 mm to 25.90 ± 0.02 mm and a MIC of 2.0 µg/mL against C. gloeosporioides. FTIR and NMR confirmed aromatic and carbonyl groups; HPLC revealed a 20.25 min retention time; and mass spectrometry detected a molecular ion peak at m/z 180.75. Time-course assays showed reduced spore viability at 16 h, while membrane assays indicated nucleotide leakage.
conclusionsP. fluorescens and its phenazine metabolite demonstrate strong biocontrol potential. Future work should focus on bioreactor-scale production and mode-of-action studies for integrated disease management.
Indexed as
Identifiers
40779220What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.